Skip to main content

Table 3 Characteristics of patients referred to the model of care and who were assessed for hepatitis C

From: Linkage to hepatitis C treatment in two opioid substitution treatment units in Gothenburg, Sweden: a retrospective cohort study

 

Treatment (n = 19)

No treatment (n = 6)

Genotype

 1a

8

2

 2

2

1

 3

8

3

 4

1

0

Fibroscan, fibrosis stagea,b

 F0-F1

10

5

 F2

7

1

 F3

0

0

 F4

1

0

  1. aOne patient who received treatment had undergone a liver biopsy
  2. bF0-F1 ≤ 7 kPa, F 7–9.5 kPa, F3 = 9.5–12.5 kPa, F4 =  ≥ 12.5 kPa (cirrhosis)
Back to article page

Substance Abuse Treatment, Prevention, and Policy

ISSN: 1747-597X